Post-marketing safety monitoring of tirzepatide: a pharmacovigilance study based on the FAERS database
This pharmacovigilance study identified both known and novel ADEs of tirzepatide, highlighting gender differences and reporting biases. Close monitoring and further research are needed to ensure its safe use.
Authors
- Yongqi Shan
- Han Chen (ORCID: https://orcid.org/0000-0002-1525-392X)
- Y. Ding (ORCID: https://orcid.org/0009-0002-5429-9995)
Institutions
- Shenyang Pharmaceutical University (CN)
- General Hospital of Shenyang Military Region (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2025-03-04
- DOI
- https://doi.org/10.1080/14740338.2025.2468860
- Citations
- 4
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 5.23